High bioavailability of bisphenol A from sublingual exposure

Environmental Health Perspectives

Volumn 121, Issue 8, 2013, Pages 951-956

  Gayrard, Véronique ^a,b   Lacroix, Marlène Z ^a,b   Collet, Séverine H ^a,b   Viguié, Catherine ^a,b   Bousquet Melou, Alain ^a,b   Toutain, Pierre Louis ^a,b   Picard Hagen, Nicole ^a,b  

^a CEMAGREF   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Bioavailability; Bisphenol A; Endocrine disruptor; Pharmacokinetic analysis; Sublingual exposure

Indexed keywords

4, 4' ISOPROPYLIDENEDIPHENOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CHROMATOGRAPHY; COMPARATIVE STUDY; CONTROLLED STUDY; DOG; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; GASTROINTESTINAL TRACT; LIMIT OF QUANTITATION; MALE; MAXIMUM PLASMA CONCENTRATION; MOUTH CAVITY; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL;

ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; ANIMALS; BENZHYDRYL COMPOUNDS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; ENVIRONMENTAL POLLUTANTS; FEMALE; GLUCURONIDES; MALE; MASS SPECTROMETRY; PHENOLS;

EID: 84881014058     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1206339     Document Type: Article

References (33)

1. Barsuhn CL, Olanoff LS, Gleason DD, Adkins EL, Ho NF. 1988. Human buccal absorption of flurbiprofen. Clin Pharmacol Ther 44:225-231.
2. Cabaton NJ, Wadia PR, Rubin BS, Zalko D, Schaeberle CM, Askenase MH, et al. 2011. Perinatal exposure to environmentally relevant levels of bisphenol A decreases fertility and fecundity in CD1 mice. Environ Health Perspect 119:547-552.
3. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. 2008. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 116:39-44.
4. Cutler D. 1981. Assessment of rate and extent of drug absorption. Pharmacol Ther 14:123-160.
5. Dekant W, Völkel W. 2008. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol 228:114-134.
6. Doerge DR, Twaddle NC, Vanlandingham M, Fisher JW. 2010a. Pharmacokinetics of bisphenol A in neonatal and adult Sprague-Dawley rats. Toxicol Appl Pharmacol 247:158-165.
7. Doerge DR, Twaddle NC, Woodling KA, Fisher JW. 2010b. Pharmacokinetics of bisphenol A in neonatal and adult rhesus monkeys. Toxicol Appl Pharmacol 248:1-11.
8. EFSA (European Food Safety Authority). 2006. Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food on a request from the Commission related to 2,2bis(4hydroxyphenyl)propane (bisphenol A). EFSA J 428:13-75. Available: http://www.efsa.europa.eu/fr/scdocs/doc/428.pdf [accessed 28 June 2012].
9. Ema M, Fujii S, Furukawa M, Kiguchi M, Ikka T, Harazono A. 2001. Rat twogeneration reproductive toxicity study of bisphenol A. Reprod Toxicol 15:505-523.
10. FAO/WHO (Food and Agriculture Organization of the United Nations/World Health Organization). 2010. Joint FAO/WHO Expert Meeting to Review Toxicological and Health Aspects of Bisphenol A: Summary Report Including Report of Stakeholder Meeting on Bisphenol A. Available: http://www.who.int/foodsafety/chem/chemicals/BPA_Summary2010.pdf [accessed 28 June 2012].
11. Geens T, Aerts D, Berthot C, Bourguignon JP, Goeyens L, Lecomte P, et al. 2012. A review of dietary and non-dietary exposure to bisphenolA. Food Chem Toxicol 50:3725-3740.
12. Kosarac I, Kubwabo C, Lalonde K, Foster W. 2012. A novel method for the quantitative determination of free and conjugated bisphenol A in human maternal and umbilical cord blood serum using a twostep solid phase extraction and gas chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 898:90-94.
13. Lacroix MZ, Puel S, Collet SH, Corbel T, PicardHagen N, Toutain PL, et al. 2011. Simultaneous quantification of bisphenol A and its glucuronide metabolite (BPAG) in plasma and urine: applicability to toxicokinetic investigations. Talanta 85:2053-2059.
14. Mielke H, GundertRemy U. 2009. Bisphenol A levels in blood depend on age and exposure. Toxicol Lett 190:32-40.
15. Patel VF, Liu F, Brown MB. 2011. Advances in oral transmucosal drug delivery. J. Control Release 153:106-116.
16. Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, et al. 2007. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 24:199-224.
17. Shojaei AH. 1998. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharmaceut Sci 1:15-30
18. Sieli PT, Jašarevic E, Warzak DA, Mao J, Ellersieck MR, Liao C, et al. 2011. Comparison of serum bisphenol A concentrations in mice exposed to bisphenol A through the diet versus oral bolus exposure. Environ Health Perspect 119:1260-1265.
19. Sohlberg E, Halldin MM, Annas A, Königsson K, Jansson B, Pehrson R, et al. 2013. The impact of the site of blood sampling on pharmacokinetic parameters following sublingual dosing to dogs. J Pharmacol Toxicol Methods 67:1-4.
20. Taylor JA, vom Saal FS, Welshons WV, Drury B, Rottinghaus G, Hunt PA, et al. 2011. Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ Health Perspect 119:422-430.
21. Teeguarden JG, Calafat AM, Ye X, Doerge DR, Churchwell MI, Gunawan R, et al. 2011. Twentyfour hour human urine and serum profiles of bisphenol A during highdietary exposure. Toxicol Sci 123:48-57.
22. Tominaga T, Negishi T, Hirooka H, Miyachi A, Inoue A, Hayasaka I, et al. 2006. Toxicokinetics of bisphenol A in rats, monkeys and chimpanzees by the LCMS/MS method. Toxicology 226:208-217.
23. Tyl RW, Myers CB, Marr MC, Sloan CS, Castillo NP, Veselica MM, et al. 2008. Twogeneration reproductive toxicity study of dietary bisphenol A in CD1 (Swiss) mice. Toxicol Sci 104:362-384.
24. Tyl RW, Myers CB, Marr MC, Thomas BF, Keimowitz AR, Brine DR, et al. 2002. Threegeneration reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol Sci 68:121-146.
25. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. 2010. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 118:1055-1070.
26. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. 2007. Human exposure to bisphenol A (BPA). Reprod Toxicol 24:139-177.
27. Vandenberg LN, Maffini MV, Schaeberle CM, Ucci AA, Sonnenschein C, Rubin BS, et al. 2008. Perinatal exposure to the xenoestrogen bisphenolA induces mammary intraductal hyperplasias in adult CD1 mice. Reprod Toxicol 26:210-219.
28. Van Landuyt KL, Nawrot T, Geebelen B, De Munck J, Snauwaert J, Yoshihara K, et al. 2011. How much do resin-based dental materials release? A meta-analytical approach. Dent Mater 27:723-747.
29. Völkel W, Colnot T, Csanady GA, Filser JG, Dekant W. 2002. Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem Res Toxicol 15:1281-1287.
30. vom Saal FS, Hughes C. 2005. An extensive new literature concerning lowdose effects of bisphenol A shows the need for a new risk assessment. Environ Health Perspect 113:926-933.
31. Weiss M. 1990. Use of metabolite AUC data in bioavailability studies to discriminate between absorption and first-pass extraction. Clin Pharmacokinet 18:419-422.
32. Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C, et al. 2007. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24:178-198.
33. Xue J, Zartarian V, Moya J, Freeman N, Beamer P, Black K, et al. 2007. A metaanalysis of children's handtomouth frequency data for estimating nondietary ingestion exposure. Risk Anal 27:411-420.